Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$62.30M$62.30Mderived+40.1% vs Q4 2013 Net Income-$3.36M-$3.36MderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$44,975,000+48.1% Operating Incomederived$4,184,000−64.7% Operating Cash Flowderived$975,000−88.2% Free Cash Flowderived-$1,928,000N/M Margins · derivedGross margin72.2%+3.9 pt vs Q4 2013
Operating margin6.7%−19.9 pt vs Q4 2013
Net margin-5.4%−17.3 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 16, 2015 · 75 d after period end